Gemini Clinical Trial Site 19 — Indianapolis, Indiana

Gemini Clinical Trial Site 19 is a clinical research site located in Indianapolis, Indiana, United States 46290.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Gemini Clinical Trial Site 19 has participated in 1 clinical trials.

Therapeutic areas: Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration.

Sponsors: Gemini Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gemini Clinical Trial Site 19?

Gemini Clinical Trial Site 19 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gemini Clinical Trial Site 19 conducted?

Gemini Clinical Trial Site 19 has 1 clinical trials on record. Their work covers Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration.

Is Gemini Clinical Trial Site 19 accredited by Crixeo Clinical Trials?

Gemini Clinical Trial Site 19 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Gemini Clinical Trial Site 19?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.